Today: 1 May 2026
BP stock slides in London as $5 billion write-down warning puts buyback in focus
15 January 2026
2 mins read

BP stock slides in London as $5 billion write-down warning puts buyback in focus

London, Jan 15, 2026, 08:32 GMT — Regular session

  • BP shares dipped in early trading following the announcement of up to $5 billion in low-carbon impairments
  • Company also cautioned that softer oil trading and declining prices are set to drag on fourth-quarter earnings
  • With Feb. 10 earnings in sight, analysts are zeroing in on buybacks and the balance sheet

BP shares slipped in early London trade Thursday following a warning of as much as $5 billion in impairments for the fourth quarter, largely from its low-carbon ventures. The oil giant also signaled weaker oil trading ahead.

The stock dipped around 2.3%, hovering near 433 pence, following a close of 443.5 pence on Wednesday, according to data from .

This update is key as BP pushes to persuade investors that its renewed focus on oil and gas will boost returns, despite weaker crude prices and increasing pressure on cash payouts. The warning came ahead of its full-year results set for Feb. 10.

BP confirmed that the $4 billion to $5 billion charge won’t impact its “underlying replacement cost profit” — a key profit metric that adjusts net income by excluding certain one-offs. The company didn’t specify which projects took the hit. Reuters

It warned that softer oil trading and falling commodity prices will drag on Q4 earnings, projecting a $200 million to $400 million hit from lower oil prices and an additional $100 million to $300 million hit from weaker gas prices.

RBC analyst Biraj Borkhataria described the move as “a first step in new management ‘clearing the decks,’” suggesting the “next logical step” would be slashing the buyback to zero to boost deleveraging. Both Citi and RBC analysts anticipate BP will scale back its share buyback programme. Reuters

BP is repurchasing roughly $750 million worth of shares every quarter. Its low-carbon assets feature U.S. biogas firm Archaea, which Citi analysts suggested could be tied to the recent impairments.

The company is scaling back on transition spending and reworking its renewable portfolio, which involves plans to sell its stake in Lightsource bp and spin off its offshore wind operations into a joint venture.

BP projects net debt will drop to between $22 billion and $23 billion by the close of 2025, down from $26.1 billion at the end of Q3. This improvement is driven by $5.3 billion in divestments, the company said. That estimate does not factor in expected proceeds from a planned majority stake sale in Castrol, which BP anticipates will bring in around $6 billion.

Shareholder politics remain a hot spot. Climate activist group Follow This, joined by over 20 investors, has filed resolutions pressing BP and Shell to reveal how they plan to generate value if oil and gas demand falls, the group said Wednesday.

Oil prices dropped over 2% in early Asian trade Thursday following remarks from U.S. President Donald Trump that eased concerns about Iran, creating fresh pressure on crude-related earnings.

BP’s guidance, however, clarifies how much of the hit is just accounting rather than cash flow. The impairments won’t affect the company’s preferred underlying profit metric, but they could raise concerns about the economics of projects and upcoming investments.

Investors will get their next clear update on Feb. 10, when BP releases its results and is expected to provide details on buybacks, debt reduction, and asset sales, including the planned Castrol deal.

Stock Market Today

  • Investors Eye FTSE 250's Applied Nutrition as Diageo Shares Falter
    May 1, 2026, 11:39 AM EDT. Diageo shares have slumped about 30% over the past year and more than 50% in five years, pressuring investors. Applied Nutrition, a FTSE 250 nutritional supplement supplier, offers a contrasting growth story with a 57% rise in sales over six months and a near 90% rise in share price over one year. The company benefits from booming health and wellness trends, expects 8% market growth annually through 2028, and features strong financials including a £25.4 million net cash position, 49% return on capital, and a modest forward price-to-earnings ratio of 17.5. Its business-to-business model with retailers like Tesco and Amazon helps navigate industry competition. Investors seeking to recover losses from Diageo may consider Applied Nutrition's robust outlook and expanding market.

Latest article

Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus

Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus

1 May 2026
Tempus AI will report first-quarter results on May 5 and hold its first investor day on May 29. Merck’s CEO highlighted Tempus in remarks on the drugmaker’s AI efforts in precision oncology. Tempus shares traded near $55.44 Friday, with a market value of about $9.7 billion. The company reported 2025 revenue of $1.27 billion and forecast $1.59 billion for 2026.
Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

1 May 2026
Rothschild & Co Redburn initiated Ciena with a Neutral rating and a $416 target, about 22% below Friday’s $534.43 share price, citing that much of the optical-networking upside is already priced in. Ciena reported Q1 revenue of $1.43 billion, up 33%, and raised its 2026 forecast. The company will showcase new optical products at ABRINT 2026 in São Paulo next week.
OpenAI’s $10B Cerebras compute deal: 750MW push to make ChatGPT faster
Previous Story

OpenAI’s $10B Cerebras compute deal: 750MW push to make ChatGPT faster

Lloyds share price nudges higher as Morgan Stanley flags UK bank upside ahead of Jan 29 results
Next Story

Lloyds share price nudges higher as Morgan Stanley flags UK bank upside ahead of Jan 29 results

Go toTop